Results with the use of human ovarian cancer cell lines showed that the BRD4-L mRNA expression is required to generate both isoforms (BRD4-L and BRD4-S), and that the BRD4-S knockdown is associated with increased expression of BRD4-L. Here, BRD4 is linked to ovarian cancer.